- Home
- OKYO vs ZTEK Comparison
OKYO vs ZTEK Comparison
Compare OKYO & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OKYO | ZTEK |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.3M | 68.8M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | OKYO | ZTEK |
|---|---|---|
| Price | $1.51 | $0.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.33 | N/A |
| AVG Volume (30 Days) | ★ 98.0K | 71.2K |
| Earning Date | 07-18-2025 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.03 | $0.52 |
| 52 Week High | $3.35 | $1.84 |
Technical Indicators
Market Signals| Indicator | OKYO | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 34.82 | 26.30 |
| Support Level | N/A | N/A |
| Resistance Level | $1.74 | $0.75 |
| Average True Range (ATR) | 0.13 | 0.04 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 16.06 | 2.94 |
Price Performance
Historical ComparisonAbout OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.